{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:18:58Z","timestamp":1790198338802,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91765-8","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T09:59:34Z","timestamp":1741082374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current prevalence of hepatitis delta diagnosis in Valencia, Spain"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6105-6740","authenticated-orcid":false,"given":"Enrique","family":"Ortega Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2546-105X","authenticated-orcid":false,"given":"Mar\u00eda Dolores","family":"Ocete Moch\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2427-3068","authenticated-orcid":false,"given":"Mar\u00eda","family":"Mart\u00ednez-Roma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3778-5337","authenticated-orcid":false,"given":"Concepci\u00f3n","family":"Gimeno Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4923-0371","authenticated-orcid":false,"given":"Neus","family":"G\u00f3mez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8583-2433","authenticated-orcid":false,"given":"Mois\u00e9s","family":"Diago Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8488-0372","authenticated-orcid":false,"given":"Alba","family":"Carrodeguas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8599-7482","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Gonz\u00e1lez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5472-1532","authenticated-orcid":false,"given":"Marta Plaza","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5969-1059","authenticated-orcid":false,"given":"Miguel","family":"Garc\u00eda Deltoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"91765_CR1","doi-asserted-by":"publisher","unstructured":"Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011; 378(9785):73\u201385. Epub 20110420. https:\/\/doi.org\/10.1016\/S0140-6736(10)61931-9.","DOI":"10.1016\/S0140-6736(10)61931-9"},{"issue":"10","key":"91765_CR2","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","volume":"221","author":"Z Miao","year":"2020","unstructured":"Miao, Z. et al. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J. Infect. Dis. 221(10), 1677\u20131687. https:\/\/doi.org\/10.1093\/infdis\/jiz633 (2020).","journal-title":"J. Infect. Dis."},{"issue":"8","key":"91765_CR3","doi-asserted-by":"publisher","first-page":"e43362","DOI":"10.7759\/cureus.43362","volume":"15","author":"Z Abbas","year":"2023","unstructured":"Abbas, Z. & Abbas, M. An insight into the factors affecting the prevalence and natural history of hepatitis D. Cureus. 15(8), e43362. https:\/\/doi.org\/10.7759\/cureus.43362 (2023).","journal-title":"Cureus."},{"issue":"5","key":"91765_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/HEP.0000000000000642","volume":"79","author":"RG Gish","year":"2024","unstructured":"Gish, R. G. et al. Association of hepatitis delta virus with liver morbidity and mortality: A systematic literature review and meta-analysis. Hepatology. 79(5), 1129\u20131140. https:\/\/doi.org\/10.1097\/HEP.0000000000000642 (2024).","journal-title":"Hepatology."},{"issue":"3","key":"91765_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","volume":"73","author":"AJ Stockdale","year":"2020","unstructured":"Stockdale, A. J. et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J. Hepatol. 73(3), 523\u2013532. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.008 (2020).","journal-title":"J. Hepatol."},{"issue":"3","key":"91765_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4254\/wjh.v10.i3.352","volume":"10","author":"R Chauhan","year":"2018","unstructured":"Chauhan, R. et al. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. World J. Hepatol. 10(3), 352\u2013370. https:\/\/doi.org\/10.4254\/wjh.v10.i3.352 (2018).","journal-title":"World J. Hepatol."},{"key":"91765_CR7","doi-asserted-by":"publisher","first-page":"S1126","DOI":"10.1016\/s0168-8278(23)03249-x","volume":"78","author":"M Casado","year":"2023","unstructured":"Casado, M. et al. Current status of hepatitis delta in Andalusia: multicenter study. J. Hepatol. 78, S1126. https:\/\/doi.org\/10.1016\/s0168-8278(23)03249-x (2023).","journal-title":"J. Hepatol."},{"issue":"4","key":"91765_CR8","first-page":"281","volume":"65","author":"JM Wilson","year":"1968","unstructured":"Wilson, J. M. & Jungner, Y. G. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam. 65(4), 281\u2013393 (1968).","journal-title":"Bol Oficina Sanit Panam."},{"key":"91765_CR9","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection: web annex B: evidence-to-decision making tables and GRADE tables. [Internet] 2024; (accessed on 07-05-2024). Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240090903."},{"key":"91765_CR10","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 67(2), 370\u2013398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021 (2017).","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"91765_CR11","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines on hepatitis delta virus. J. Hepatol. 79(2), 433\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.001 (2023).","DOI":"10.1016\/j.jhep.2023.05.001"},{"issue":"10","key":"91765_CR12","doi-asserted-by":"publisher","first-page":"100547","DOI":"10.1016\/j.jhepr.2022.100547","volume":"4","author":"A Palom","year":"2022","unstructured":"Palom, A. et al. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D. JHEP Rep. 4(10), 100547. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100547 (2022).","journal-title":"JHEP Rep."},{"issue":"4","key":"91765_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v13040555","volume":"13","author":"M Rizzetto","year":"2021","unstructured":"Rizzetto, M. & Stroffolini, T. Forty-five years after the discovery of the hepatitis D virus: Where do we stand?. Viruses. 13(4), 1. https:\/\/doi.org\/10.3390\/v13040555 (2021).","journal-title":"Viruses."},{"issue":"2","key":"91765_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/jvh.13899","volume":"31","author":"A Demirel","year":"2024","unstructured":"Demirel, A. et al. Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?. J. Viral. Hepat. 31(2), 120\u2013128. https:\/\/doi.org\/10.1111\/jvh.13899 (2024).","journal-title":"J. Viral. Hepat."},{"issue":"41","key":"91765_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030400","volume":"101","author":"E Ortega-Gonzalez","year":"2022","unstructured":"Ortega-Gonzalez, E. et al. HIV screening and linkage to care in a health department in Valencia, Spain: Lessons learned from a healthcare quality improvement project. Medicine (Baltimore). 101(41), e30400. https:\/\/doi.org\/10.1097\/MD.0000000000030400 (2022).","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"91765_CR16","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.2196\/resprot.3378","volume":"3","author":"TH Sanchez","year":"2014","unstructured":"Sanchez, T. H. et al. A novel approach to realizing routine HIV screening and enhancing linkage to care in the United States: Protocol of the FOCUS program and early results. JMIR Res. Protoc. 3(3), e39. https:\/\/doi.org\/10.2196\/resprot.3378 (2014).","journal-title":"JMIR Res. Protoc."},{"key":"91765_CR17","unstructured":"DiaSorin. LIAISON\u00ae XL Anti-HDV. Total automation for an accurate, easy and fast HDV diagnosis. (2020). Available from: https:\/\/hdv.diasorin.com\/ese%20antiHDV%204330-A%2008-2018%20low.pdf."},{"key":"91765_CR18","unstructured":"Altona Diagnostics. Instructions for Use RealStar\u00ae HDV RT-PCR Kit 1.0(2018 November 27th 2024). Available from: https:\/\/altona-diagnostics.com\/wp-content\/uploads\/2023\/12\/RealStar-HDV-RT-PCR-Kit-1.0_WEB_RUO_EN-S01.pdf."},{"key":"91765_CR19","doi-asserted-by":"publisher","first-page":"107131","DOI":"10.1016\/j.ijid.2024.107131","volume":"146","author":"E Ortega Gonzalez","year":"2024","unstructured":"Ortega Gonzalez, E. et al. Opportunistic population screening as a hepatitis elimination strategy: the CRIVALVIR-FOCUS program. Int. J. Infect. Dis. 146, 107131. https:\/\/doi.org\/10.1016\/j.ijid.2024.107131 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"91765_CR20","unstructured":"Limia Sanchez, A., & Olmedo Luceron, C. [2(nd) Seroprevalence Study in Spain, 2017\u20132018]. Rev Esp Salud Publica. 95. Epub 20210318 (2021)."},{"issue":"4","key":"91765_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cld.2021.06.001","volume":"25","author":"I Tout","year":"2021","unstructured":"Tout, I., Loureiro, D. & Asselah, T. The Changing Demographics of Hepatitis B Virus Infection. Clin Liver Dis. 25(4), 673\u2013687. https:\/\/doi.org\/10.1016\/j.cld.2021.06.001 (2021).","journal-title":"Clin Liver Dis."},{"issue":"3","key":"91765_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jhep.2020.06.037","volume":"73","author":"H Wedemeyer","year":"2020","unstructured":"Wedemeyer, H. The burden of hepatitis D - defogging the epidemiological horizon. J. Hepatol. 73(3), 493\u2013495. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.037 (2020).","journal-title":"J. Hepatol."},{"issue":"9","key":"91765_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/MEG.0000000000001163","volume":"30","author":"A Aguilera","year":"2018","unstructured":"Aguilera, A. et al. Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain. Eur. J. Gastroenterol. Hepatol. 30(9), 1060\u20131062. https:\/\/doi.org\/10.1097\/MEG.0000000000001163 (2018).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"91765_CR24","doi-asserted-by":"publisher","first-page":"S1098","DOI":"10.1016\/s0168-8278(23)03208-7","volume":"78","author":"S Rodriguez-Tajes","year":"2023","unstructured":"Rodriguez-Tajes, S. et al. Characterizing chronic hepatitis delta in Spain and the gaps in its management. J. Hepatol. 78, S1098. https:\/\/doi.org\/10.1016\/s0168-8278(23)03208-7 (2023).","journal-title":"J. Hepatol."},{"issue":"4","key":"91765_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cld.2023.05.010","volume":"27","author":"DW Yen","year":"2023","unstructured":"Yen, D. W., Soriano, V., Barreiro, P. & Sherman, K. E. Triple threat: HDV, HBV, HIV coinfection. Clin. Liver Dis. 27(4), 955\u2013972. https:\/\/doi.org\/10.1016\/j.cld.2023.05.010 (2023).","journal-title":"Clin. Liver Dis."},{"key":"91765_CR26","doi-asserted-by":"publisher","first-page":"S1122","DOI":"10.1016\/s0168-8278(23)03244-0","volume":"78","author":"L Piermatteo","year":"2023","unstructured":"Piermatteo, L. et al. Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli. J. Hepatol. 78, S1122\u2013S1123. https:\/\/doi.org\/10.1016\/s0168-8278(23)03244-0 (2023).","journal-title":"J. Hepatol."},{"key":"91765_CR27","doi-asserted-by":"publisher","first-page":"S903","DOI":"10.1016\/S0168-8278(23)02418-2","volume":"78","author":"V Cossiga","year":"2023","unstructured":"Cossiga, V. et al. Implementation of anti-HDV reflex testing among HBsAg-positive in a tertiary center in South Italy. J. Hepatol. 78, S903 (2023).","journal-title":"J. Hepatol."},{"key":"91765_CR28","doi-asserted-by":"publisher","first-page":"S1090","DOI":"10.1016\/s0168-8278(23)03198-7","volume":"78","author":"T Herta","year":"2023","unstructured":"Herta, T. et al. Hepatitis D screening in HBsAg positive individuals in Germany: insufficient implementation results in a large number of undiagnosed cases. J. Hepatol. 78, S1090\u2013S1091. https:\/\/doi.org\/10.1016\/s0168-8278(23)03198-7 (2023).","journal-title":"J. Hepatol."},{"key":"91765_CR29","doi-asserted-by":"publisher","first-page":"S1111","DOI":"10.1016\/S0168-8278(23)03227-0","volume":"78","author":"M Cardoso","year":"2023","unstructured":"Cardoso, M. et al. Predominance of genotype 5 hepatitis delta virus infection in a Portuguese centre. J. Hepatol. 78, S1111 (2023).","journal-title":"J. Hepatol."},{"key":"91765_CR30","doi-asserted-by":"publisher","first-page":"S1158","DOI":"10.1016\/S0168-8278(23)03295-6","volume":"78","author":"R Truchi","year":"2023","unstructured":"Truchi, R., De Monte, A., Tran, A., Giordanengo, V. & Ollier, L. Positive impact of reflex testing in performing hepatitis delta serology in HBsAg+ patients. J. Hepatol. 78, S1158\u2013S1159 (2023).","journal-title":"J. Hepatol."},{"key":"91765_CR31","doi-asserted-by":"publisher","first-page":"S905","DOI":"10.1016\/S0168-8278(23)02424-8","volume":"78","author":"I Carey","year":"2023","unstructured":"Carey, I. et al. Hepatitis D infection in a HBsAg cohorts referred from specialist liver clinics vs. reflex community referred patients in South East London. J. Hepatol. 78, S905\u2013S906 (2023).","journal-title":"J. Hepatol."},{"issue":"24","key":"91765_CR32","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1001\/jama.2023.23242","volume":"330","author":"F Negro","year":"2023","unstructured":"Negro, F. & Lok, A. S. Hepatitis D: A review. JAMA. 330(24), 2376\u20132387. https:\/\/doi.org\/10.1001\/jama.2023.23242 (2023).","journal-title":"JAMA."},{"issue":"8","key":"91765_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jval.2020.03.014","volume":"23","author":"J Williams","year":"2020","unstructured":"Williams, J. et al. An economic evaluation of the cost-effectiveness of opt-out hepatitis B and hepatitis C testing in an emergency department setting in the United Kingdom. Value Health. 23(8), 1003\u20131011. https:\/\/doi.org\/10.1016\/j.jval.2020.03.014 (2020).","journal-title":"Value Health."},{"issue":"8","key":"91765_CR34","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1007\/s10620-020-06584-w","volume":"66","author":"NA Terrault","year":"2021","unstructured":"Terrault, N. A. & Ghany, M. G. Enhanced screening for hepatitis D in the USA: Overcoming the delta blues. Dig. Dis. Sci. 66(8), 2483\u20132485. https:\/\/doi.org\/10.1007\/s10620-020-06584-w (2021).","journal-title":"Dig. Dis. Sci."},{"key":"91765_CR35","doi-asserted-by":"publisher","first-page":"S896","DOI":"10.1016\/S0168-8278(23)02407-8","volume":"78","author":"M Buti","year":"2023","unstructured":"Buti, M. et al. Impact of the anti-HDV reflex testing on the reduction of hepatitis D burden in Spain. J. Hepatol. 78, S896 (2023).","journal-title":"J. Hepatol."},{"key":"91765_CR36","unstructured":"Cabezas, J., Aguilera, A., Berenguer, M., Buti, M., Forns, X., et al. Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we? Vienna (Austria), EASL Congress [Internet] 2023; (accessed on 03-02-2025). Available from: https:\/\/www.postersessiononline.eu\/173580348_eu\/congresos\/ILC2023\/aula\/-FRI_188_ILC2023.pdf."},{"key":"91765_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/DDDT.S379964","volume":"17","author":"V Soriano","year":"2023","unstructured":"Soriano, V., Moreno-Torres, V., Trevino, A., Corral, O. & de Mendoza, C. Bulevirtide in the treatment of hepatitis delta: Drug discovery, clinical development and place in therapy. Drug. Des. Dev. Ther. 17, 155\u2013166. https:\/\/doi.org\/10.2147\/DDDT.S379964 (2023).","journal-title":"Drug. Des. Dev. Ther."},{"key":"91765_CR38","doi-asserted-by":"publisher","first-page":"105553","DOI":"10.1016\/j.jcv.2023.105553","volume":"167","author":"JM Ramos-Rincon","year":"2023","unstructured":"Ramos-Rincon, J. M. et al. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain. J. Clin. Virol. 167, 105553. https:\/\/doi.org\/10.1016\/j.jcv.2023.105553 (2023).","journal-title":"J. Clin. Virol."},{"issue":"1","key":"91765_CR39","doi-asserted-by":"publisher","first-page":"502226","DOI":"10.1016\/j.gastrohep.2024.502226","volume":"48","author":"P Parada Vazquez","year":"2025","unstructured":"Parada Vazquez, P. et al. Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnes (Spain). Gastroenterol Hepatol. 48(1), 502226. https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502226 (2025).","journal-title":"Gastroenterol Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91765-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91765-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91765-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T09:59:39Z","timestamp":1741082379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91765-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91765"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91765-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AC and JLG-S own stock and are employees of Gilead Sciences. The remaining authors declare no conflicts of interest concerning the research, authorship, and publication of this article. Data collection and management were conducted independently, with additional oversight of independent data monitoring agencies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7584"}}